Volume 184, Issue 2

Search all Breast Cancer Research and Treatment articles

November 2020

Filter by

Volume:

Sort by

Date published:

New to old Old to new

36 articles in this issue

Revisiting the internal mammaries as recipient vessels in breast reconstruction: considerations in current practice
Steven M. Sultan
Amanda M. Rizzo
Katie E. Weichman
Review 04 September 2020 Pages: 255 - 264
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway
Arielle L. Heeke
Joanne Xiu
Antoinette R. Tan
Preclinical study 10 August 2020 Pages: 265 - 275
Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma
Momoko Akashi
Rin Yamaguchi
Hirohisa Yano
Preclinical study 08 August 2020 Pages: 277 - 285
BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating Notch1 signaling in breast cancer
Jian Chen
Yuan-Hui Lai
Tian-Yu Liu
Preclinical study 08 August 2020 Pages: 287 - 300
Receipt of psychological counseling and integrative medicine services among breast cancer survivors with anxiety
Kelly M. Trevino
Neil Iyengar
Jun J. Mao
Preclinical study 09 August 2020 Pages: 301 - 310
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Ramona Erber
Matthias Rübner
Peter A. Fasching
Preclinical study Open access 27 August 2020 Pages: 311 - 324
Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer
Ji-Yeon Kim
Hae Hyun Jung
Young-Hyuck Im
Preclinical study 18 August 2020 Pages: 325 - 334
Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer
J. Michael Dixon
Julia Grewar
Arran Turnbull
Clinical trial Open access 18 August 2020 Pages: 335 - 343
The impact of co-surgeons on complication rates and healthcare cost in patients undergoing microsurgical breast reconstruction: analysis of 8680 patients
Malke Asaad
Ying Xu
Alexander F. Mericli
Clinical trial 16 August 2020 Pages: 345 - 356
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy
Carly Bess Williams
Caroline A. Nebhan
Ann Richmond
Clinical trial 07 August 2020 Pages: 357 - 364
Part of 1 collection:

Immunotherapy for Breast Cancer
Patterns in detection of recurrence among patients treated for breast cancer
Lena Saltbæk
Trine Allerslev Horsboel
Susanne Oksbjerg Dalton
Clinical trial 06 August 2020 Pages: 365 - 373
Single-port laparoscopically harvested omental flap for immediate breast reconstruction
Eun-Kyu Kim
Sumin Chae
Sang-Hoon Ahn
Clinical trial 06 August 2020 Pages: 375 - 384
Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?
Coco J. E. F. Walstra
Robert-Jan Schipper
Regina G. H. Beets-Tan
Clinical trial Open access 08 August 2020 Pages: 385 - 395
Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer
Zhao Bi
Peng Chen
Yong-Sheng Wang
Clinical trial 10 August 2020 Pages: 397 - 405
Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments
Joana Reis
Jonas Christoffer Lindstrøm
Jonn Terje Geitung
Clinical trial Open access 12 August 2020 Pages: 407 - 420
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study
Francesco Schettini
Navid Sobhani
Daniele Generali
Clinical trial Open access 07 August 2020 Pages: 421 - 431
Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy
Cynthia D’Hondt
Marian Vanhoeij
Michel De Vos
Clinical trial 13 August 2020 Pages: 433 - 444
Factors associated with falls in older women with breast cancer: the use of a brief geriatric screening tool in clinic
David B. Bartlett
Gloria Broadwater
Gretchen Kimmick
Clinical trial 13 August 2020 Pages: 445 - 457
Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial
S. L. Kilbreath
L. C. Ward
D. Black
Clinical trial 18 August 2020 Pages: 459 - 467
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)
Santiago González-Santiago
Cristina Saura
José Ignacio Chacón
Clinical trial 02 September 2020 Pages: 469 - 479
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
Sacha J. Howell
Faye Coe
Maria Ekholm
Clinical trial Open access 29 August 2020 Pages: 481 - 489
Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing
Valerie Shilling
Susan Catt
Lesley Fallowfield
Clinical trial Open access 18 August 2020 Pages: 491 - 498
Increasing accrual of minority patients in breast cancer clinical trials
Amelia A. Trant
Lucas Walz
Andrea Silber
Clinical trial 25 August 2020 Pages: 499 - 505
A population-based study of invitation to and participation in clinical trials among women with early-stage breast cancer
Monica A. Patel
Jennifer L. Shah
Christine M. Veenstra
Epidemiology 05 August 2020 Pages: 507 - 518
Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison
Anna Z. de Boer
Willemien van de Water
Martine Extermann
Epidemiology Open access 19 August 2020 Pages: 519 - 526
Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type
Jiyoung Kim
Jee Ye Kim
Korean Breast Cancer Society
Epidemiology 13 August 2020 Pages: 527 - 542
Risk factors for inflammatory and non-inflammatory breast cancer in North Africa
Catherine Schairer
Ahmed Hablas
Amr S. Soliman
Epidemiology 02 September 2020 Pages: 543 - 558
Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine
Shayma Kazmi
Debanjana Chatterjee
Peter A. Kaufman
Epidemiology Open access 17 August 2020 Pages: 559 - 565
Physicians’ attitudes towards reproduction in young patients with early breast cancer in China
Yuzhu Zhang
Liping Dian
Rui Xu
Epidemiology Open access 10 August 2020 Pages: 567 - 583
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study
Rin Ogiya
Naoki Niikura
Hiromitsu Jinno
Epidemiology 20 August 2020 Pages: 585 - 596
Nomograms for prediction of overall and cancer-specific survival in young breast cancer
Yi Sun
Yuqiang Li
Fengyan Yu
Epidemiology 04 September 2020 Pages: 597 - 613
Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer
Eun Ji Sim
Kwang-Pil Ko
Sue K. Park
Epidemiology 17 October 2020 Pages: 615 - 626
Analyzing non-sentinel axillary metastases in patients with T3–T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy
Fabian Riedel
Joerg Heil
André Hennigs
Epidemiology Open access 20 August 2020 Pages: 627 - 636
Management of early breast cancer during the COVID-19 pandemic in Brazil
Francisco Pimentel Cavalcante
Guilherme Garcia Novita
Ruffo Freitas Junior
Epidemiology 16 August 2020 Pages: 637 - 647
Association of RAD51C germline mutations with breast cancer among Bahamians
Maryam Bagherzadeh
Agata Szymiczek
Mohammad R. Akbari
Brief Report 18 August 2020 Pages: 649 - 651
Letter to the editor Re: Pan et al. "LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer"
Renba Liang
Letter to the Editor 14 August 2020 Pages: 653 - 653

Volume 184, Issue 2

Revisiting the internal mammaries as recipient vessels in breast reconstruction: considerations in current practice

Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway

Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma

BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating Notch1 signaling in breast cancer

Receipt of psychological counseling and integrative medicine services among breast cancer survivors with anxiety

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients

Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer

Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer

The impact of co-surgeons on complication rates and healthcare cost in patients undergoing microsurgical breast reconstruction: analysis of 8680 patients

Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy

Patterns in detection of recurrence among patients treated for breast cancer

Single-port laparoscopically harvested omental flap for immediate breast reconstruction

Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?

Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer

Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy

Factors associated with falls in older women with breast cancer: the use of a brief geriatric screening tool in clinic

Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial

Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)

Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)

Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing

Increasing accrual of minority patients in breast cancer clinical trials

A population-based study of invitation to and participation in clinical trials among women with early-stage breast cancer

Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison

Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type

Risk factors for inflammatory and non-inflammatory breast cancer in North Africa

Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine

Physicians’ attitudes towards reproduction in young patients with early breast cancer in China

Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study

Nomograms for prediction of overall and cancer-specific survival in young breast cancer

Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer

Analyzing non-sentinel axillary metastases in patients with T3–T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy

Management of early breast cancer during the COVID-19 pandemic in Brazil

Association of RAD51C germline mutations with breast cancer among Bahamians

Letter to the editor Re: Pan et al. "LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer"

Navigation